Triptan medication for migraine, min. 3 purchases

TRIPTANS3

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N02CC

31789

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

16908

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

16908

diagram downward connector

Include endpoints None

16908

diagram downward connector
TRIPTANS3

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 16358 14034 2324
Unadjusted prevalence (%) 5.30 8.09 1.72
Mean age at first event (years) 36.98 36.56 39.52

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.99 [0.74, 1.33] 9.5e-1 191
15 years 0.01 0.78 [0.56, 1.08] 1.3e-1 90
5 years 0.00 1.00 [0.62, 1.62] 9.9e-1 23
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: TRIPTANS3 – Triptan medication for migraine, min. 3 purchases
GWS hits:

Survival analyses between endpoints

Plot

before Triptan medication for migraine, min. 3 purchases
after Triptan medication for migraine, min. 3 purchases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Triptan medication for migraine, min. 3 purchases